Varian Medical Systems (VAR) Tops Q1 EPS by 4c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Varian Reports Results for First Quarter of Fiscal Year 2021
January 26, 2021 4:09 PM ESTPALO ALTO, Calif., Jan. 26, 2021 /PRNewswire/ --
First Quarter 2021 Summary
Oncology Systems gross orders grew 2% in dollars or 1% in constant currency in the quarter; trailing twelve months gross orders down 5% in dollars or 6% in constant currency 13 EthosTM orders received, including 8 in the Americas, 4 in EMEA, and 1 in Asia-Pacific 1 Proton order awarded in China Total company revenues down 6% in dollars, or 8% in constant currency, to $779 million GAAP operating earnings grew 7% at 15.1% of revenues; non-GAAP operating earnings grew 1% at 17.5% of revenues GAAP net earnings per diluted... More